Aligos Therapeutics, Inc
Aligos Therapeutics, Inc. is a biotechnology company based in South San Francisco, CA, focused on developing best-in-class therapies for liver and viral diseases, particularly chronic hepatitis B virus infection and metabolic dysfunction-associated steatohepatitis. With a strong foundation in medicinal chemistry and biology, the company aims to address significant unmet medical needs through targeted drug development.
The company's pipeline includes innovative oral small molecule therapies, such as ALG-000184, a capsid assembly modulator for chronic HBV infection, and ALG-055009, a thyroid hormone receptor beta agonist for MASH. Aligos is committed to improving patient outcomes by leveraging the expertise of its experienced team, which has a successful track record from discovery to commercialization in hepatology and virology.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.